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In 2005, we assessed the seroprevalence of neutral-
izing antibodies to avian inﬂ  uenza virus A (H5N1) among 
901 residents of 4 villages in Thailand where at least 1 con-
ﬁ  rmed human case of inﬂ  uenza (H5N1) had occurred dur-
ing 2004. Although 68.1% of survey participants (median 
age 40 years) were exposed to backyard poultry and 25.7% 
were exposed to sick or dead chickens, all participants were 
seronegative for inﬂ  uenza virus (H5N1).
T
hree apparent waves of highly pathogenic avian inﬂ  u-
enza virus A (H5N1) infection in humans occurred in 
Thailand from early 2004 through 2006; these waves, which 
corresponded to inﬂ  uenza (H5N1) outbreaks in poultry, re-
sulted in 25 conﬁ  rmed human cases and 17 deaths (1–4). 
However, the frequency of asymptomatic and clinically 
mild cases of inﬂ  uenza (H5N1) infection was unknown 
in areas where these outbreaks occurred. In 2005, we con-
ducted a cross-sectional seroprevalence study of inﬂ  uenza 
virus (H5N1) antibodies among residents of 4 rural villages 
in Thailand where at least 1 human inﬂ  uenza (H5N1) case 
had occurred in 2004. Backyard poultry farming is com-
mon in these villages, but the villages have no live poultry 
markets.
Methods
The study was conducted during October 11–27, 2005, 
among residents of 4 rural villages in central and north-
ern Thailand where inﬂ  uenza (H5N1) outbreaks in poultry 
and human inﬂ  uenza (H5N1) cases had occurred: village A 
in Prachin Buri Province (1 conﬁ  rmed case), village B in 
Kamphaeng Phet Province (1 probable case, 1 conﬁ  rmed 
case), village C in Sukhothai Province (1 conﬁ  rmed case), 
and village D in Phetchabun Province (1 conﬁ  rmed case) 
(Figure). Illness onset in these case-patients occurred from 
August 31 through October 8, 2004. Residents of any of the 
villages for at least 2 weeks before and after illness onset 
of the respective case-patient in each village were eligible 
to participate in the study. Participants were enrolled by 
random selection from lists of village residents or by con-
venience sampling. Village residents were excluded if they 
had inﬂ  uenza (H5N1) diagnosed from August 17 through 
October 22, 2004, were <18 years of age and did not have 
parental consent, had an underlying coagulopathy, or were 
taking anticoagulant drugs within 2 weeks of enrollment. 
Written informed consent was obtained from all study par-
ticipants or their proxies.
Using a standard questionnaire, trained interviewers 
collected demographic and exposure data through brief 
face-to-face interviews with study participants. Exposure 
was deﬁ  ned as either direct contact (touching) or close 
contact (within 1 m without direct contact) with chickens 
or other poultry or with a person with conﬁ  rmed inﬂ  uenza 
(H5N1) infection. A 5-mL blood specimen was collected 
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2007, at the Options for the Control of Inﬂ  uenza Conference VI, 
Toronto, Ontario, Canada.Antibodies to Inﬂ  uenza Virus (H5N1), Thailand
from participants >5 years of age, and a 3-mL specimen was 
collected from those <5 years of age. Serum samples were 
separated at a local hospital and transported on wet ice to a 
laboratory within 48 h after collection. Serologic testing by 
microneutralization (MN) assay was performed in an en-
hanced biosafety level-3 containment facility in accordance 
with a slightly modiﬁ  ed version of a protocol described 
previously (5–7). Inﬂ  uenza virus A/Thailand/1(KAN-1)/
2004 (H5N1) was selected for the MN assay because of its 
antigenic similarity to inﬂ  uenza virus (H5N1) isolates from 
humans in Thailand (2). Immunoﬂ  uorescence with use of 
293T cells transfected with hemagglutinin H5N1 recom-
binant plasmid as the test antigen was used to conﬁ  rm MN 
assay results. In accordance with our modiﬁ  ed protocol, 
we considered an inﬂ  uenza virus (H5N1) neutralizing anti-
body titer >40 (equivalent to >80 in other protocols) to be 
a positive result (5–7).
Epi Info 2002 (Centers for Disease Control and Pre-
vention, Atlanta, GA, USA) was used to enter and analyze 
study data. Mean, median, and proportion values were 
calculated for variables and compared by using bivariate 
analysis. The χ2 test was used for most analyses, analysis 
of variance was used to compare means from the conve-
nience sample with those from the random sample, and the 
Fisher exact test was used if expected cell values were <5. 
Differences between the 2 sample groups were considered 
signiﬁ  cant at p<0.05. The study was approved by the Ethi-
cal Review Committee for Research in Human Subjects, 
Thai Ministry of Public Health.
Results
The study population consisted of 901 participants: 228 
from village A (28.1% of village residents), 203 from vil-
lage B (28.4%), 209 from village C (30.5%), and 260 from 
village D (19.6%). Their median age was 40 years (range 
2–101 years), and 42.4% were male. The 901 participants 
were enrolled in 2 ways: 131 (14.5%) by random selection 
(out of 838 randomly selected villagers: 15.6% participa-
tion), and 770 (85.5%) by convenience sampling. The 2 
groups of study participants did not differ signiﬁ  cantly by 
demographic characteristics, history of illness, or exposure 
to poultry (Table 1). Most participants (68.1%) reported di-
rect or close contact with backyard poultry, 25.7% reported 
direct or close contact with sick or dead chickens, and 7.1% 
reported close contact with a person with conﬁ  rmed inﬂ  u-
enza (H5N1) infection (Table 1). Of 110 participants who 
reported a history of acute respiratory symptoms, 74.5% re-
ported direct or close contact with backyard poultry, 31.8% 
reported direct or close contact with sick or dead chickens, 
and 13.6% reported close contact with a person with con-
ﬁ  rmed inﬂ  uenza (H5N1) infection (data not shown). All 
participants were seronegative for inﬂ  uenza virus (H5N1) 
neutralizing antibodies (Table 2).
Discussion
Participants in this study were from villages in central 
and northern Thailand where widespread, conﬁ  rmed out-
breaks of inﬂ  uenza (H5N1) infection in poultry and at least 
1 human inﬂ  uenza (H5N1) case had occurred during 2004. 
A substantial proportion of participants reported exposure 
to backyard poultry, including contact with sick or dead 
chickens, the primary risk factor for inﬂ  uenza (H5N1) in-
fection (8,9). Nevertheless, we found no serologic evidence 
of mild or subclinical inﬂ  uenza (H5N1) infection, suggest-
ing that clade 1 inﬂ  uenza virus A (H5N1) strains circulat-
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Figure. Province location of study villages with laboratory-
conﬁ  rmed avian inﬂ  uenza A (H5N1) cases in humans, Thailand, 
2004. (Adapted from http://commons.wikimedia.org/wiki/Image:
BlankMap_Thailand.png.)RESEARCH
ing in Thailand among backyard poultry during 2004 did 
not transmit easily to our study population.
Our ﬁ  ndings differ from those from a study of poultry 
workers in Hong Kong, among whom the estimated se-
roprevalence of inﬂ  uenza virus (H5N1) neutralizing anti-
bodies was 10% during the 1997 outbreak (10). The Hong 
Kong poultry workers, however, likely had much greater 
intensity of exposure to poultry infected with inﬂ  uenza vi-
rus (H5N1) than our study population had. Furthermore, 
the clade 1 inﬂ  uenza virus (H5N1) strains that infected 
poultry and humans in Thailand during 2004 were antigen-
ically and genetically distinct from the clade 0 inﬂ  uenza 
virus (H5N1) strains that caused the 1997 outbreak in Hong 
Kong (11). Our ﬁ  nding of no serologic evidence of asymp-
tomatic or mild inﬂ  uenza (H5N1) infection among Thai 
villagers is consistent with ﬁ   ndings from smaller inﬂ  u-
enza virus (H5N1) seroprevalence studies among workers 
in live poultry markets in the People’s Republic of China 
(12), among villagers exposed to backyard poultry infected 
with clade 1 inﬂ  uenza virus (H5N1) in rural Cambodia 
(13), among poultry workers exposed to poultry infected 
with clade 2.2 inﬂ  uenza virus (H5N1) in northern Nige-
ria (14), and among poultry farmers exposed to poultry 
infected with clade 1 inﬂ  uenza virus (H5N1) in Thailand 
(7). Results of studies conducted since 2004 thus suggest 
that the risk for inﬂ  uenza (H5N1) infection is low among 
persons exposed to infected poultry; however, our ﬁ  nding 
of no serologic evidence of asymptomatic or mild inﬂ  uenza 
(H5N1) infection among Thai villagers suggests that the 
high case-fatality proportion in Thailand (17 deaths among 
25 persons with conﬁ  rmed infection) may accurately reﬂ  ect 
the severity of the infection in Thailand.
Our study had 3 notable limitations. First, because 
study participants, most of whom were enrolled by con-
venience sampling, were generally older than the popula-
tions of the villages in which they resided (Thai Ministry of 
Public Health, unpub. data), our ﬁ  ndings may not be gen-
eralizable to these villages’ populations. Second, because 
the study was conducted in 2005, some participants may 
not have accurately recalled relevant exposures or symp-
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Table 1. Characteristics of the study population, overall and by method of selection, Thailand, 2005 
Characteristic
Random sample 
(n = 131), no. (%) 
Convenience sample 
(n = 770), no. (%)  p value 
Total sample  
(N = 901), no. (%) 
Age group, y  0.30
  1–14  19 (14.5)  178 (23.1)  197 (21.9) 
  15–29  14 (10.7)  99 (12.9)  113 (12.5) 
  30–44  37 (28.2)  177 (23.0)  214 (23.8) 
  45–59  32 (24.4)  175 (22.7)  207 (22.9) 
  60–74  24 (18.3)  109 (14.2)  133 (14.8) 
  75–89  4 (3.1)  28 (3.6)  32 (3.6) 
  90–104  1 (0.8)  4 (0.5)  5 (0.5) 
Occupation 0.04
  Plant farmer  59 (45.0)  236 (30.6)  295 (32.7) 
  Animal farmer  3 (2.3)  11 (1.4)  14 (1.6) 
  Farmer (plant and animal)  2 (1.5)  7 (1.0)  9 (0.10) 
  Merchant  2 (1.5)  13 (1.7)  15 (1.7) 
  Government officer  0 3 (0.4)  3 (0.4) 
  Other (employee, housekeeper)  42 (32.1)  346 (44.9)  388 (43.0) 
  Missing  23 (17.6)  154 (20.0)  177 (19.6) 
Sex 0.70
  Male  58 (44.3)  324 (42.1)  382 (42.4) 
  Female  73 (55.7)  446 (57.9)  519 (57.6) 
Risk factors 0.60
  Direct or close contact with backyard poultry  
 (including  chickens) 
89 (67.9)  525 (68.2)  614 (68.1) 
  Direct or close contact with backyard chickens 86 (65.6)  519 (67.4)  605 (67.1) 
  Direct or close contact with dead/sick chicken 36 (27.5)  196 (25.5)  232 (25.7) 
  Close contact with a person with a confirmed case
  of avian influenza A 
13 (9.9)  51 (6.6)  64 (7.1) 
Acute respiratory symptoms* 0.31
  Symptoms  12 (9.2)  98 (12.7)  110 (12.2) 
  No symptoms  119 (90.8)  672 (87.3)  791 (87.89) 
Influenza-like illness† 0.39
  Symptoms  7 (5.3)  61 (7.9)  68 (7.5) 
  No symptoms  124 (94.7)  709 (92.1)  833 (92.5) 
*Acute respiratory symptoms were rhinorrhea, cough, sore throat, or dyspnea. 
†Influenza-like illness was defined as a temperature >38.0°C in conjunction with any of the following: rhinorrhea, cough, sore throat, or dyspnea. Antibodies to Inﬂ  uenza Virus (H5N1), Thailand
toms from 2004 when the inﬂ  uenza (H5N1) cases occurred. 
Third, some participants with mild or asymptomatic inﬂ  u-
enza (H5N1) infection in 2004 may not have generated an 
antibody response strong enough or durable enough to be 
detected in serum samples collected in October 2005.
Further data are needed on the natural history and ki-
netics of the immune response to inﬂ  uenza (H5N1) infec-
tion over time among severely ill persons who survived, 
as well as among those with clinically mild illness. Such 
prospective serial data may help researchers interpret the 
signiﬁ  cance of low levels of inﬂ  uenza virus (H5N1) neu-
tralizing antibody titers, as well as the results of additional 
seroprevalence studies. In addition, because inﬂ  uenza 
virus (H5N1) strains continue to evolve, additional sero-
prevalence studies to estimate human risk for infection are 
needed worldwide among populations exposed to the virus, 
including poultry workers, rural residents, market workers, 
farm workers, healthcare workers, and family members of 
infected persons.
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